Merck’s call to lower the age for Gardasil HPV vaccine 'just another marketing ploy,' critic says
(Natural News) Merck researchers on Monday published a study suggesting evidence shows that moving routine HPV vaccination to ages 9 to 10 may improve vaccination coverage rates in early and mid-adolescence, but critics called out the vaccine maker for focusing on profits, not health. (Article by Suzanne Burdick, Ph.D republished from ChildrensHealthDefense.org) Merck wants children... |